Skip to Content


In the US, Ofloxacin (ofloxacin systemic) is a member of the drug class quinolones and is used to treat Anthrax, Anthrax Prophylaxis, Bladder Infection, Bone infection, Bronchitis, Campylobacter Gastroenteritis, Cervicitis, Chancroid, Chlamydia Infection, Epididymitis - Non-Specific, Epididymitis - Sexually Transmitted, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Joint Infection, Kidney Infections, Methicillin-Resistant Staphylococcus Aureus Infection, Mycobacterium avium-intracellulare - Treatment, Nongonococcal Urethritis, Pelvic Inflammatory Disease, Plague, Pneumonia, Prostatitis, Salmonella Enteric Fever, Salmonella Gastroenteritis, Shigellosis, Skin or Soft Tissue Infection, Traveler's Diarrhea, Tuberculosis - Active and Urinary Tract Infection.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Fluoroquinolone (gyrase inhibitor)

Chemical Name

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-metyl-10-(4-metyl-1-piperazinyl)-7-oxo-, (±)-

Foreign Names

Generic Names

  • Ofloxacin (OS: USAN, JAN, BAN)
  • Ofloxacina (OS: DCIT)
  • Ofloxacine (OS: DCF)
  • 83380-47-6 (IS)
  • 85344-55-4 (IS)
  • DL 8280 (IS: Daiichi Seiyaku)
  • Hoe 280 (IS: HoechstMarion)
  • ORF 18489 (IS: Ortho)
  • Ofloxacin (PH: BP 2015, JP XVI, Ph. Eur. 8, USP 37)
  • Ofloxacine (PH: Ph. Eur. 8)
  • Ofloxacinum (PH: Ph. Eur. 8)

Brand Names

International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.